Masayuki Hisada

814 total citations
31 papers, 643 citations indexed

About

Masayuki Hisada is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masayuki Hisada has authored 31 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masayuki Hisada's work include Colorectal Cancer Surgical Treatments (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Intestinal and Peritoneal Adhesions (3 papers). Masayuki Hisada is often cited by papers focused on Colorectal Cancer Surgical Treatments (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Intestinal and Peritoneal Adhesions (3 papers). Masayuki Hisada collaborates with scholars based in Japan, United States and China. Masayuki Hisada's co-authors include Takayuki Yoshimoto, Junichiro Mizuguchi, Sadahiro Kamiya, Yasuhisa Koyanagi, Maria Laura Belladonna, Koji Fujita, Akihiko Tsuchida, Kenji Katsumata, Yasuharu Mori and Zhaoli Sun and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Masayuki Hisada

27 papers receiving 632 citations

Peers

Masayuki Hisada
Manik Amin United States
Suzanne Fioravanti United States
Viralkumar Davra United States
Aihua Yao China
Manik Amin United States
Masayuki Hisada
Citations per year, relative to Masayuki Hisada Masayuki Hisada (= 1×) peers Manik Amin

Countries citing papers authored by Masayuki Hisada

Since Specialization
Citations

This map shows the geographic impact of Masayuki Hisada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Hisada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Hisada more than expected).

Fields of papers citing papers by Masayuki Hisada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Hisada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Hisada. The network helps show where Masayuki Hisada may publish in the future.

Co-authorship network of co-authors of Masayuki Hisada

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Hisada. A scholar is included among the top collaborators of Masayuki Hisada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Hisada. Masayuki Hisada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fukumoto, Tsuyoshi, et al.. (2020). A patient with cystic duct remnant calculus treated by laparoscopic surgery combined with near-infrared fluorescence cholangiography. SHILAP Revista de lepidopterología. 6(1). 146–146. 1 indexed citations
3.
Katsumata, Kenji, Yasuharu Mori, Takeshi Suda, et al.. (2019). GSTP1 as a potential predictive factor for adverse events associated with platinum‑based antitumor agent‑induced peripheral neuropathy. Oncology Letters. 17(3). 2897–2904. 8 indexed citations
4.
Koike, Junichi, Kimihiko Funahashi, Kazuhiko Yoshimatsu, et al.. (2017). Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial. Cancer Chemotherapy and Pharmacology. 79(3). 519–525. 29 indexed citations
5.
Mizoguchi, Izuru, Yukino Chiba, Masayuki Hisada, et al.. (2016). Promotion of Expansion and Differentiation of Hematopoietic Stem Cells by Interleukin-27 into Myeloid Progenitors to Control Infection in Emergency Myelopoiesis. PLoS Pathogens. 12(3). e1005507–e1005507. 55 indexed citations
6.
Okabayashi, Takehiro, Andrew M. Cameron, Masayuki Hisada, et al.. (2016). Chimeric Allografts Induced by Short‐Term Treatment With Stem Cell–Mobilizing Agents Result in Long‐Term Kidney Transplant Survival Without Immunosuppression: A Study in Rats. American Journal of Transplantation. 16(7). 2055–2065. 14 indexed citations
7.
Hisada, Masayuki. (2014). Complete laparoscopic resection of the rectum using natural orifice specimen extraction. World Journal of Gastroenterology. 20(44). 16707–16707. 49 indexed citations
8.
Ishizaki, Tetsuo, Yasuharu Hayashida, Masayuki Hisada, & Akihiko Tsuchida. (2012). A Case of Rectosigmoid Endometoriosis Treated with Laparoscopic Assisted High Anterior Resection. Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 37(6). 1142–1146. 1 indexed citations
9.
Hisada, Masayuki, Yoshiaki Ota, Xinliang Zhang, et al.. (2012). Successful Transplantation of Reduced-Sized Rat Alcoholic Fatty Livers Made Possible by Mobilization of Host Stem Cells. American Journal of Transplantation. 12(12). 3246–3256. 7 indexed citations
10.
Hisada, Masayuki, et al.. (2012). A Case Report of Preoperative Diagnosis of Aggressive Angiomyxoma. Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 37(6). 1147–1152. 1 indexed citations
11.
Okabayashi, Takehiro, Andrew Cameron, Masayuki Hisada, et al.. (2011). Mobilization of Host Stem Cells Enables Long-Term Liver Transplant Acceptance in a Strongly Rejecting Rat Strain Combination. American Journal of Transplantation. 11(10). 2046–2056. 26 indexed citations
12.
Zhang, Xiuying, Shingo Tachibana, Hua Wang, et al.. (2010). Interleukin-6 Is an Important Mediator for Mitochondrial DNA Repair After Alcoholic Liver Injury in Mice. Hepatology. 52(6). 2137–2147. 64 indexed citations
13.
Katsumata, Kenji, Yasuharu Mori, Masayuki Hisada, et al.. (2008). Oxaliplatin for Metastatic Colon Cancer in a Patient with Renal Failure. SHILAP Revista de lepidopterología. 2. 97–101. 7 indexed citations
14.
Endo, Mitsufumi, Kenji Katsumata, Yoichiro Mori, et al.. (2007). A Case of Endometriosis of the Ileum Presenting with Intestinal Obstruction. Nihon Daicho Komonbyo Gakkai Zasshi. 60(3). 186–190. 1 indexed citations
15.
Ishizaki, Tetsuo, Kenji Katsumata, Akihiko Tsuchida, et al.. (2006). Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity. International Journal of Molecular Medicine. 17(2). 357–62. 31 indexed citations
16.
Katsumata, Kenji, et al.. (2006). Detection and evaluation of epithelial cells in the blood of colon cancer patients using RT-PCR. International Journal of Clinical Oncology. 11(5). 385–389. 29 indexed citations
17.
Mori, Yasuharu, et al.. (2005). A CASE OF PROTEIN S DEFICIENCY CAUSING INTESTINAL NECROSIS DUE TO THROMBOSIS OF CRANIAL MESENTERIC VEIN. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 66(6). 1468–1472. 3 indexed citations
18.
Hisada, Masayuki, Takayuki Yoshimoto, Sadahiro Kamiya, et al.. (2004). Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT. Cancer Gene Therapy. 11(4). 280–288. 27 indexed citations
19.
Yoshimoto, Takayuki, Sadahiro Kamiya, Masayuki Hisada, et al.. (2003). Positive Modulation of IL-12 Signaling by Sphingosine Kinase 2 Associating with the IL-12 Receptor β1 Cytoplasmic Region. The Journal of Immunology. 171(3). 1352–1359. 64 indexed citations
20.
Shinagawa, N, et al.. (1992). [Postoperative infection control in patients with hepatic, biliary tract, and pancreatic cancers].. PubMed. 19(2). 173–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026